Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCI-779 in Recurrent Glioblastoma Multiforme
NCT00016328Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2001
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in glioblastoma (GBM), sponsored by National Cancer Institute. Started May 2001; status: completed.
02
Drugs
temsirolimus
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT00016328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00016328.